Crossmark

Analytical method development, validation and studies of degradation behavior of erlotinib hydrochloride in bulk and tablet formulation by thin-layer chromatography

Crossref DOI link: https://doi.org/10.1007/s00764-023-00249-w

Published Online: 2023-10-10

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Varu, Hardik L.

Jadav, Rajesh A.

Bapodra, Atul H.

Ambasana, Mrunal A.
License Information

Text and Data Mining valid from 2023-10-10

Version of Record valid from 2023-10-10
More Information

Article History

Received: 14 August 2023

Accepted: 7 September 2023

First Online: 10 October 2023

Declarations

:

: The authors declare that they have no conflicts of interest.

Document is current

Any future updates will be listed below